Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5738051 | Neuroscience Letters | 2018 | 7 Pages |
Abstract
Propofol has been demonstrated as a drug of abuse in humans. Our previous study indicated that dexamethasone, a potent agonist of glucocorticoid receptor (GR), inhibited propofol-maintained rat self-administration behaviors by systematic injection. However, the direct effect of GR in the nucleus accumbens (NAc) on propofol self-administration behavior has not been explored. The propofol-maintained self-administration was established in rats after a successive 3-h daily self-administration of propofol for 14 days. On day 15, 30 min prior to the last training, rats received one of three doses (0.3, 1.0, or 3.0 μg/site) of dexamethasone or vehicle via intra-NAc injection. The number of active nose-poke responses, propofol injections, and inactive nose-poke responses was recorded. Dopamine D1 receptor and c-Fos expressions were detected. Plasma corticosterone level was measured by enzyme-linked immunosorbent assay. Intra-NAc administration of dexamethasone (1.0 and 3.0 μg/site) facilitated the active nose-poke responses, which was accompanied by the upregulation of D1 receptor and c-Fos in the NAc. Plasma corticosterone level was not changed in dexamethasone-treated groups. This study provides crucial evidence that GR in the NAc plays an important role in regulating propofol self-administration behaviors in rats, which may be mediated by changes in D1 receptor and c-Fos expressions, and this also needs further examination with GR antagonist in the future.
Related Topics
Life Sciences
Neuroscience
Neuroscience (General)
Authors
Binbin Wu, Wenxuan Lin, Hong Wang, Taha Abdullah, Benfu Wang, Ying Su, Ren-Shan Ge, Qingquan Lian,